- Gastroenterology Education and CPD for trainees and specialists - https://www.gastrotraining.com -

Drug No Help for Survival in Advanced Gastric Ca

(MedPage Today) — SAN FRANCISCO -– Adding the targeted agent everolimus (Afinitor) to best supportive care in patients with advanced gastric cancer failed to significantly improve overall survival, a researcher said here.


Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com